Sangamo Therapeutics (SGMO)

Add to Watchlists
Create an Alert
9.30 +0.10  +1.09% NASDAQ Jun 23, 16:47 Delayed 2m USD

Sangamo Therapeutics Net Income (Quarterly):

-16.63M for March 31, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Sangamo Therapeutics Net Income (Quarterly) Chart

Export Data
Save Image
Print Image

Sangamo Therapeutics Historical Net Income (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 -16.63M
Dec. 31, 2016 -9.624M
Sept. 30, 2016 -18.96M
June 30, 2016 -26.58M
March 31, 2016 -16.49M
Dec. 31, 2015 -14.01M
Sept. 30, 2015 -9.245M
June 30, 2015 -12.13M
March 31, 2015 -5.319M
Dec. 31, 2014 -4.319M
Sept. 30, 2014 -7.545M
June 30, 2014 -6.981M
March 31, 2014 -7.572M
Dec. 31, 2013 -8.144M
Sept. 30, 2013 -6.145M
June 30, 2013 -5.45M
March 31, 2013 -6.885M
Dec. 31, 2012 -3.478M
Sept. 30, 2012 -5.79M
June 30, 2012 -5.728M
March 31, 2012 -7.268M
Dec. 31, 2011 -6.359M
Sept. 30, 2011 -9.554M
June 30, 2011 -10.26M
March 31, 2011 -9.578M
   
Dec. 31, 2010 -8.321M
Sept. 30, 2010 -8.695M
June 30, 2010 -3.86M
March 31, 2010 -3.978M
Dec. 31, 2009 -2.393M
Sept. 30, 2009 -4.851M
June 30, 2009 -4.511M
March 31, 2009 -6.832M
Dec. 31, 2008 -2.574M
Sept. 30, 2008 -6.34M
June 30, 2008 -7.419M
March 31, 2008 -7.972M
Dec. 31, 2007 -6.672M
Sept. 30, 2007 -4.268M
June 30, 2007 -5.181M
March 31, 2007 -5.359M
Dec. 31, 2006 -8.948M
Sept. 30, 2006 -2.845M
June 30, 2006 -3.327M
March 31, 2006 -2.744M
Dec. 31, 2005 -2.693M
Sept. 30, 2005 -3.667M
June 30, 2005 -3.38M
March 31, 2005 -3.553M
Dec. 31, 2004 -3.043M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Advertisement

SGMO Net Income (Quarterly) Benchmarks

Companies
Conatus Pharmaceuticals -3.623M
Pfizer 3.121B
Capricor Therapeutics -3.667M

SGMO Net Income (Quarterly) Range, Past 5 Years

Minimum -26.58M Jun 2016
Maximum -3.478M Dec 2012
Average -9.852M

SGMO Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Latest data point: =YCP("SGMO", "net_income")
  • Last 5 data points: =YCS("SGMO", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.